Published in Hum Genet on April 11, 2011
Direct-to-consumer personalized genomic testing. Hum Mol Genet (2011) 1.61
Direct-to-Consumer Genetic Testing and Personal Genomics Services: A Review of Recent Empirical Studies. Curr Genet Med Rep (2013) 1.16
State of play in direct-to-consumer genetic testing for lifestyle-related diseases: market, marketing content, user experiences and regulation. Proc Nutr Soc (2013) 0.99
Neither as harmful as feared by critics nor as empowering as promised by providers: risk information offered direct to consumer by personal genomics companies. J Community Genet (2012) 0.97
Harm, hype and evidence: ELSI research and policy guidance. Genome Med (2013) 0.94
Field of genes: an investigation of sports-related genetic testing. J Pers Med (2012) 0.86
Genomic medicine and neurological disease. Hum Genet (2011) 0.85
Health care providers and direct-to-consumer access and advertising of genetic testing in the United States. Genome Med (2011) 0.78
Associations between self-referral and health behavior responses to genetic risk information. Genome Med (2015) 0.76
Effect of direct-to-consumer genomewide profiling to assess disease risk. N Engl J Med (2011) 6.90
Disclosure of APOE genotype for risk of Alzheimer's disease. N Engl J Med (2009) 6.43
Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev (2010) 3.25
A systematic review of perceived risks, psychological and behavioral impacts of genetic testing. Genet Med (2008) 3.06
Science and regulation. Regulating direct-to-consumer personal genome testing. Science (2010) 2.40
Consumer perceptions of direct-to-consumer personalized genomic risk assessments. Genet Med (2010) 2.23
Genomics. Deflating the genomic bubble. Science (2011) 2.20
Is modern genetics a blind alley? Yes. BMJ (2010) 2.03
Which way for genetic-test regulation? Assign regulation appropriate to the level of risk. Nature (2010) 1.55
Willingness-to-pay for predictive tests with no immediate treatment implications: a survey of US residents. Health Econ (2010) 1.43
Willingness to pay for genetic testing: a study of attitudes in a Canadian population. Public Health Genomics (2009) 1.10
Being more realistic about the public health impact of genomic medicine. PLoS Med (2010) 1.06
Understanding FDA regulation of DTC genetic tests within the context of administrative law. Am J Hum Genet (2010) 0.96
Direct-to-consumer genetic testing - where should we focus the policy debate? Med J Aust (2013) 0.75